Duopharma Biotech has expanded over the decades to support local healthcare alongside Malaysia’s development.
The Company’s formal history began with the establishment of Duopharma (M) Sendirian Berhad in 1978 and the incorporation of Duopharma Biotech in 2000. Today, as a leading publicly-traded Malaysian pharmaceutical company, Duopharma Biotech focuses on growing its portfolio in the Manufacturing, Research & Development and Commercialisation & Marketing of generic drugs and biosimilars, to deliver high quality, innovative and accessible solutions across Malaysia and the world over.
Establishment of Duopharma (M) Sendirian Berhad as a trading company
Listed on Bursa Malaysia
Chemical Company of Malaysia Berhad (CCMB) acquired Duopharma Biotech Berhad
Duopharma Biotech Berhad rebranded as CCM Duopharma Biotech Berhad (CCMD)
Restructuring of pharmaceutical companies under CCMD
Demerger of CCMD from CCMB
CCMD changed its name to Duopharma Biotech Berhad
Commercialisation of selected speciality products at HAPI Plant
Participated in the national vaccination programme on the provision of Covid-19 vaccines
Received first Halal-Certified Cancer Treatment
Establishment of PT Duopharma Healthcare Indonesia, a wholly-owned subsidiary of Duopharma Biotech Berhad